Europe
Seventure Partners today announces its corporate update for the period May-August 2018.
Forendo Commences Phase Ia Study for FOR-6219 for Endometriosis
Tanja Bosshard Becker joined Executive Insight in 2007 as a consultant.
Karolinska Development’s portfolio company Forendo Pharma announces today that Vesalius Biocapital III Partners (Vesalius) joins Forendo Pharma’s existing international investor syndicate.
Fruquintinib capsules provide a new oral treatment option for patients with metastatic colorectal cancer and will be marketed as Elunate®
Notice of Allowance received from US patent and trademark office relating to ImmTAC® platform
Development collaboration integrates Sartorius Stedim Biotech’s BIOSTAT® STR bioreactors and Repligen’s XCell™ ATF cell retention control technology
Biom’up today announces Dr. Peter Byloos’ co-optation to its Board of Directors as an independent director.
Hemogenyx Pharmaceuticals Plc announces that its CEO, Dr. Vladislav Sandler, will present at the Kennedy Institute of Rheumatology conference ‘From Laboratory to Clinic: Accelerating Experimental Medicine Approaches’ taking place at Trinity College, Oxford, from Tuesday 4 September until Friday 7 September 2018.
TissUse has signed a collaboration agreement with Bayer to develop a highly innovative liver-endocrine tissues assay using TissUse’s Multi-Organ-Chip (MOC) technology.
PRESS RELEASES